MED ED THREAD TWO
Emerging Therapies and Shared Decision-Making
Advancing Equitable Care in Anemia of CKD: Minimizing Disease Burden and Health Disparities with Novel Agents and Shared Decision-Making
Jay B. Wish, MD
Milda Saunders, MD, MPH
Associate Professor of Medicine
Section of General Internal Medicine
University of Chicago
Edgar Lerma, MD
Clinical Professor of Medicine
Section of Nephrology
University of Illinois at Chicago
Upon completion of this activity, the participant should be able to:
- Summarize the mechanism of action and clinical trial efficacy and safety data of HIF-PH inhibitors.
- Explain the application of shared decision-making principles to enhance patient engagement and improve outcomes in the care of patients with anemia in CKD.
Physician Accreditation Statement
Physician Credit Designation
Instructions to Receive Credit
- Read the learning objectives and faculty disclosures Complete the pretest
- View the enduring material
- Complete the posttest with a score of 70% or higher
A statement of credit will be issued within four weeks of receipt of a completed activity evaluation form.
Fee Information and Refund/Cancellation Policy
Disclosures of Relevant Financial Relationships
All relevant financial relationships have been mitigated.
The faculty have the following relevant financial relationships with ineligible companies:
Consulting Fee (e.g., Advisory Board): GlaxoSmithKline, Fibrogen, AstraZeneca, Akebia, Otsuka, Rockwell Medical, CSL Behring, Disc Medicine
Milda Saunders, MD, MPH has no relevant financial relationships to disclose.
Edgar Lerma, MD
Speakers' Bureaus: AstraZeneca, Callidita, GlaxoSmithKline, Otsuka, Travere
Disclosure of Unlabeled Use
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
This activity is jointly provided by Global Education Group and Iridium Continuing Education.
This educational activity is supported by an independent educational grant from GlaxoSmithKline.